Company Announcements

VANCOUVER, British Columbia--(BUSINESS WIRE)--Feb. 11, 2026-- AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:

• TD Cowen 46th Annual Health Care Conference, March 4, 2026
• KeyBanc Capital Markets Healthcare Forum, March 17, 2026
• Bloom Burton & Co.Healthcare Investor Conference, April 21-22, 2026

A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260210650979/en/

Inquiries
Media: Tiffany Chiu; media@abcellera.com, +1(236)521-6774
Partnering: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005
Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.